Prior C-Sections and Blood Proteins in Pregnancy
Part of Women’s health & pregnancy clinical trials.
This study looks at how the number of previous C-sections affects certain proteins (called angiogenic factors) in the blood. It may help doctors understand risks for women who have had prior C-sections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 36 weeks pregnant.
- You are pregnant with one baby (not twins or more).
- You have had a previous cesarean section.
- You do not have any of these conditions: vasculitis, chronic endometritis, lupus, kidney failure, liver disease, thrombocytopenia (low platelets).
- You do not smoke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood markers (called angiogenic factors) can help manage high blood pressure in pregnancy without having to deliver the baby early. If you have gestational hypertension, this trial may help doctors decide the best way to keep you and your baby healthy.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This study looks at women who have a pregnancy located in the scar from a past cesarean section. It aims to see how the type of scar pregnancy relates to the number of previous c-sections.
This study looks at how blood vessels adapt during late pregnancy, especially around the time of a C-section. Your participation may help researchers understand normal pregnancy changes and how they differ in certain complications.
This study looks at a possible link between certain proteins in the blood (VEGF family) and a pregnancy condition called placenta previa, using genetic information from existing studies. It is not a treatment trial, but a research study that analyzes data to understand causes.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
Hear when a new Cesarean Section trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.